Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
N/A
This is a multicenter study to evaluate the safety and clinical outcomes of...
Status
Enrolling By Invitation
Location
University of California, Irvine
Start Date
2023-05-16
Trial ID
NCT05897957
The Safety, Tolerability, and Efficacy of Dopaminergic Neural Progenitor Cells (XS411CN Cell Injection) for the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P).
PHASE1
A Phase I Study to Assess the Safety, Tolerability and Efficacy of dopamine...
Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery
PHASE1
This clinical trial is designed to evaluate the safety, tolerability and pr...